You are here: Industry Insights > oncology

News List

Has the booming PD-1 inhibitor reached its limit? Krebs Qin
October 18, 2024
In the field of oncology, Opdivo and Keytruda, as core immunotherapy agents for PD-1 inhibitors, have delivered significant survival benefits to patients with a variety of cancers.
Future Prospects of Small Molecule and Monoclonal Antibody Drugs in Oncology and Immunology Krebs Qin
October 18, 2024
Specifically, there is a balance between small molecules and monoclonal antibody drugs (mAbs) in the realm of oncology super blockbuster drugs, while immunology appears dominated by monoclonal antibodies and protein-based treatments.
What To Expect in the 2024 Pharmaceutical Market Suzanne Elvidge
January 12, 2024
The pharmaceutical market is growing fast. According to Statista.The largest market is oncology, predicted to be worth US$214.10 billion in 2024.
A Review of Oncology Biosimilars Products and Companies David Orchard-Webb
May 12, 2022
Biologics and biosimilars are large and generally complex therapeutics produced from living organisms.
The Last Ten Shanghai STAR Market Pharmaceutical IPOs David Orchard-Webb
March 16, 2022
The last ten biopharma companies that have IPO’d on the STAR Market (Shanghai Stock Exchange Science and Technology Innovation Board) are focused on oncology, synthetic biology, genomics, HIV & pain management...
NASDAQ Biopharma IPOs in the First Half of Q1 2022 David Orchard-Webb
March 01, 2022
So far in the first half of Q1 2022 seven biopharma companies have IPO’d on the NASDAQ.
Advancing oncology Sarah Harding
March 18, 2021
With so much going on last year, you might be forgiven if you missed a ground-breaking announcement in November 2020 about the ‘Galleri blood test’.
Insights Into the Oncology Landscape in China Neeta Ratanghayra
December 24, 2020
Significant increases in incidence rates have made cancer a high priority in China. Despite major government reforms to reduce cancer burdens, problems remain. To fulfill its agenda in cancer innovation, China is embracing new frontiers and opportunities.
Pharmaceutical News of the Week (June. 29th-July. 3rd) | PharmaSources.com - Updates on M&A, IPO and Others PharmaSources/Caicai
July 08, 2020
Let’s review the hot events of the pharmaceutical industry this week. The news involved 5 sections: approval, R&D, policies, transactions and listing that happened during June 29-July 3, including 29 pieces.
Latest Data of InnoCare’s Robust Oncology Pipelines Presented at the 2022 ASCO Annual Meeting PharmaSources.com
June 07, 2022
Latest data of InnoCare’s robust oncology pipeline were presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page